Lipocine Inc. - Common Stock — 재무제표 (NASDAQ:LPCN) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 25.35 M52.48 M37.54 M23 M22.51 M17.01 M 총 부채 10.01 M6.91 M1.91 M2.63 M1.51 M2.53 M 자본금 총액 15.34 M45.57 M35.63 M20.37 M21 M14.48 M 총 부채 및 주주자본 25.35 M52.48 M37.54 M23 M22.51 M17.01 M 총부채 5.59 M2.31 M———— 순부채 5.59 M-42.31 M————

뉴스

Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates

BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Beats Revenue Estimates

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%

Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock?

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

Lipocine completes patient visits in phase 3 trial for PPD treatment

H.C. 웨인라이트, 라이포신 목표 주가 15달러로 상향 조정

H.C. Wainwright raises Lipocine stock price target to $15 on PPD trial progress

Lipocine completes enrollment in phase 3 trial for PPD treatment

리포신, 긍정적 안전성 검토 후 PPD 약물 임상 지속

Lipocine’s PPD drug trial continues after positive safety review

리포신, 산후 우울증 치료제 임상 80% 등록 완료